
§ Funding Round
Series D funding round for Revance Therapeutics raising $45M in June 2011
Series D funding round for Revance Therapeutics raising $45M in June 2011
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Essex WoodlandsLEAD | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Palo Alto Investors | — | — |
| Organization | — | |
| Organization | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$284M
Top Valuation
-
Revance Therapeutics raised $45M in a Series D round.
The round was announced on 06/01/11.
The round was led by Essex Woodlands, novaquest capital management.